Register entry
Melinta Therapeutics, LLC
- Registered sites
- 0
- Drug products
- 11
- Live patents
- 8
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
8Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| KIMYRSA | ORITAVANCIN DIPHOSPHATE | Aug 2029 |
| KIMYRSA | ORITAVANCIN DIPHOSPHATE | Apr 2030 |
| KIMYRSA | ORITAVANCIN DIPHOSPHATE | Jul 2035 |
| ORBACTIV | ORITAVANCIN DIPHOSPHATE | Aug 2029 |
| ORBACTIV | ORITAVANCIN DIPHOSPHATE | Apr 2030 |
| ORBACTIV | ORITAVANCIN DIPHOSPHATE | Jul 2035 |
Catalogue
Marketed products
11Showing 11 of 11.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Baxdela | delafloxacin meglumine | TABLET | NDA |
| Baxdela | delafloxacin meglumine | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| Kimyrsa | oritavancin diphosphate | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| Minocin | minocycline hydrochloride | INJECTION | NDA |
| Orbactiv | oritavancin | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| REZZAYO | rezafungin | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| TOPROL XL | Metoprolol Succinate | TABLET, EXTENDED RELEASE | NDA |
| TOPROL XL | Metoprolol Succinate | TABLET, EXTENDED RELEASE | NDA |
| TOPROL XL | Metoprolol Succinate | TABLET, EXTENDED RELEASE | NDA |
| TOPROL XL | Metoprolol Succinate | TABLET, EXTENDED RELEASE | NDA |
| VABOMERE | Meropenem-Vaborbactam | INJECTION, POWDER, FOR SOLUTION | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.